TW200514552A - A constituent for preventing of memory lose and dementia - Google Patents
A constituent for preventing of memory lose and dementiaInfo
- Publication number
- TW200514552A TW200514552A TW092128775A TW92128775A TW200514552A TW 200514552 A TW200514552 A TW 200514552A TW 092128775 A TW092128775 A TW 092128775A TW 92128775 A TW92128775 A TW 92128775A TW 200514552 A TW200514552 A TW 200514552A
- Authority
- TW
- Taiwan
- Prior art keywords
- dementia
- constituent
- preventing
- memory
- lose
- Prior art date
Links
- 206010012289 Dementia Diseases 0.000 title abstract 2
- 239000000470 constituent Substances 0.000 title abstract 2
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 abstract 2
- 239000010282 Emodin Substances 0.000 abstract 2
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 abstract 2
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 abstract 2
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 abstract 2
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 abstract 2
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 abstract 2
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW92128775A TWI259771B (en) | 2003-10-16 | 2003-10-16 | A medical composition for treatments and prevention of memory lose |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW92128775A TWI259771B (en) | 2003-10-16 | 2003-10-16 | A medical composition for treatments and prevention of memory lose |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200514552A true TW200514552A (en) | 2005-05-01 |
| TWI259771B TWI259771B (en) | 2006-08-11 |
Family
ID=37872507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW92128775A TWI259771B (en) | 2003-10-16 | 2003-10-16 | A medical composition for treatments and prevention of memory lose |
Country Status (1)
| Country | Link |
|---|---|
| TW (1) | TWI259771B (zh) |
-
2003
- 2003-10-16 TW TW92128775A patent/TWI259771B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| TWI259771B (en) | 2006-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1894564A3 (en) | Use of an ibat inhibitor for the treatment of prophylaxis of constipation | |
| IL158559A (en) | Use of 5-lipoxygenase inhibitors for the preparation of a pharmaceutical composition for treating acne | |
| AP2004003161A0 (en) | Substituted benzazoles and use thereof as raf kinase inhibitors. | |
| MY135721A (en) | Amidino compounds useful as nitric oxide synthase inhibitors | |
| MXPA05013147A (es) | Preparacion solida. | |
| MXPA03008045A (es) | Nuevas composiciones de medicamentos en base a agentes anticolinergicos e inhibidores de pde-iv. | |
| TR200502508T2 (tr) | IL-18 İnhibitörlerinin kullanımı. | |
| AP2005003227A0 (en) | Synergistic combination of an alpha-2-delta ligandand a PDEV inhibitor for use in the treatment of pain. | |
| EP1419785A4 (en) | MEDICAMENTS CONTAINING A CHYMASE INHIBITOR AND ACE INHIBITOR AS ACTIVE INGREDIENTS | |
| AU2002328494A1 (en) | Drugs containing chymase inhibitor and ACE inhibitor as the active ingredients | |
| AU2003293555A1 (en) | 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
| WO2003088748A8 (en) | Use of heme oxygenase-1 and products of heme degradation | |
| WO2004087066A3 (en) | Hif-1 inhibitors | |
| ZA200208228B (en) | Use of il-18 inhibitors for the treatment and/or prevention of athesclerosis | |
| WO2006016262A8 (en) | Combination of a selective noradrenaline reuptake inhibitor and a pdev inhibitor | |
| UA90249C2 (uk) | Комбінація, що містить кандесартан та розувастатин, фармацевтична композиція, яка її містить, та застосування | |
| AR043327A1 (es) | Uso de inhibidores de quinurenina 3- hidroxilasa para el tratamiento de la diabetes | |
| EP1541139A4 (en) | DRUG COMPOSITION WITH NF-KAPPA B HEMMER | |
| WO2004083173A3 (en) | Ketopiperazine derivatives as bradykinin antagonists | |
| ZA200502464B (en) | Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome. | |
| MXPA04006498A (es) | Indanos e indanonas y su uso en perfumeria. | |
| HUP0300990D0 (en) | Synergistic combination for the prophylaxis and treatment of diabetes | |
| MXPA04001230A (es) | Uso de inhibidores de il-18 en desordenes de hipersensibilidad. | |
| MX2007007355A (es) | 5-(2,2-dimetil-ciclopropil)-3-metil-pen-2-en nitrilo como fragancia y sabor. | |
| WO2000074667A3 (en) | Compositions active in telomere damage comprising a taxane and telomerase inhibitor |